Skip to content

Hypertensive Heart Disease in DR Congo

Comorbidities and the Management of Hypertensive Heart Disease in a Low-Resource Setting: A Cross-Sectional Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06524440
Enrollment
400
Registered
2024-07-29
Start date
2024-07-26
Completion date
2024-07-29
Last updated
2024-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertensive Heart Disease

Keywords

Comorbidities, Democratic Republic of Congo, Hypertensive heart disease, Management

Brief summary

In this Cross-sectional study, we will analyzed data from a tertiary referral Congolese hospital to find whether or not Congolese patients with hypertensive heart disease have multiple comorbid conditions. Will report on the management and outcomes of the patients.

Detailed description

This will be done by collecting individual data on BMI, dyslipidemia, stroke, diabetes, serum creatinine, HDL, LDL, and urea levels for patients diagnosed with hypertensive heart disease.

Interventions

None listed

Sponsors

Association of Future African Neurosurgeons, Yaounde, Cameroon
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Patients is 18 year or older * Patient is diagnosed with hypertensive heart disease

Exclusion criteria

* Patient is not 18 year or older * Patient is not diagnosed with hypertensive heart disease

Design outcomes

Primary

MeasureTime frameDescription
High Systolic Blood Pressure1 monthThe study will use high systolic blood pressures as a measure for hypertensive heart disease.

Countries

Democratic Republic of the Congo

Contacts

Primary ContactUlrick S Kanmounye, MD(c)
ulricksidney@gmail.com781 658 4443
Backup ContactJonathan A Nuamah, MD(c)
jonathan.a.nuamah@gmail.com(0)203701316

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026